Published by TMR Research Insights
Posted on August 5, 2021
5 min readLast updated: February 18, 2026
Add as preferred source on Google
Smart Inhalers Market: Overview
Smart inhalers, also known as connected inhalers and sensors are predominantly used as clip-on sensors, which are fastened on top of a regular nebulizer for the treatment of chronic obstructive pulmonary disorder (COPD) and asthma. Smart inhaler technology is birthing as one of the most notable areas that pharmaceutical companies are engaged in order to push digital health.
Read Report Overview – https://www.transparencymarketresearch.com/smart-inhalers-market.html
Smart inhalers help patients keep track of dosage of relievers or preventers that are administered at various intervals during the day. These smart devices can raise reminders and alerts for users based on previous pattern of dosage administration or based on inputs fed by users.
Smart Inhalers Market: Key Trends
The growth of the smart inhalers market is attributed to increasing air pollution, increasing incidence of respiratory diseases such as COPD and asthma, and burden on healthcare services due to higher cases of COPD and asthma. In addition, increasing adoption of smart inhalers for proper management of COPD and asthma are further boosting the market’s growth.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21014
Top pharmaceutical companies are adopting digital technology in their way for improved disease management such as that for asthma and COPD and for improving the efficacy of prescribed medicines. Extensive benefits that range from reducing hospital admissions to improving the efficacy of medicines, makes smart inhalers the talk of the town in the respiratory care segment.
However, high costs involved in the treatment of COPD and asthma due to their chronic nature, limited availability of smart inhalers, and misinterpretation of information are expected to challenge the market’s growth.
Smart Inhalers Market: Market Potential
The efficacy and ability for the smart management of respiratory diseases has called in for smart inhalers to enter the U.K healthcare system, as per a recent industry news. The impending entry of smart inhalers in the National Health Service (NHS) might herald the onset of the smart healthcare age. However, proper planning and rigorous testing is needed before smart inhalers ensure smart-enabled healthcare delivers best outcomes for individuals with asthma, adds the NHS.
Request for Analysis of COVID19 Impact on Smart Inhalers Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=21014
Smart Inhalers Market: Regional Outlook
On the regional perspective, Europe has emerged as the second largest market for smart inhalers. This is because smart inhalers are increasingly being adopted in hospitals and physicians’ offices, thereby boosting the market growth. The European Academy of Allergy & Clinical Immunology is continuously striving to increase awareness about COPD and asthma and the use of technology for smart management of these conditions.
North America stood as the largest revenue generator for the market in the recent past, whereas Asia Pacific is expected to rise at a double-digit growth rate over the next few years. Asia Pacific has vast untapped opportunities in the smart inhalers market as it has a growing population base combined with rising disposable incomes and increasing awareness about the use of digital devices for proper disease management.
Pre Book Smart Inhalers Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=21014<ype=S
Smart Inhalers Market: Competitive Landscape
Some important players in the smart inhalers market include Teva Pharmaceuticals Industries Ltd., Vectura Group plc, AstraZeneca plc, Propeller Health, Adherium Limited, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Cohero Health LLC, OPKO Health Inc., and Novartis AG.
Of these, Adherium is a key player in the market with majority of product approvals to its credit. Because smart inhalers is a lucrative market, collaborations and acquisitions between pharmaceutical companies, smart inhaler manufacturers, and medical device companies is on the rise for larger market share. Key players in the smart inhalers market are also focused on product approval and clinical trials to stay competitive in this market.
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research – https://www.transparencymarketresearch.com/healthcare-market-reports-42.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Transparency Market Research
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Blog: https://tmrblog.com/
Follow Us: Twitter | LinkedIn
They are connected inhalers or clip-on sensors fastened to regular nebulizers for treating COPD and asthma. They track dosage and can send reminders and alerts to users.
Rising air pollution, increasing incidence of respiratory diseases like COPD and asthma, and pressure on healthcare services are key drivers. Broader adoption of digital technology by top pharma companies also supports growth.
High treatment costs due to the chronic nature of COPD and asthma, limited availability of smart inhalers, and risks of misinterpreting information are expected challenges.
North America has been the largest revenue generator recently, with Europe the second largest. Asia Pacific is expected to grow at a double‑digit rate over the next few years.
Key players include Teva Pharmaceutical Industries, Vectura Group, AstraZeneca, Propeller Health, Adherium, GlaxoSmithKline, and Boehringer Ingelheim.
Explore more articles in the Research Reports category
